Vincristine-induced neuropathy: Atypical electrophysiological patterns in children

Muscle and Nerve

Volumn 52, Issue 6, 2015, Pages 981-985

  Courtemanche, Hélène ^a   Magot, Armelle ^a,b   Ollivier, Yolaine ^a   Rialland, Fanny ^c   Leclair Visonneau, Laurène ^a   Fayet, Guillemette ^a   Camdessanché, Jean Philippe ^d   Péréon, Yann ^a,b  

^a HÔTEL DIEU   (France)

^b NANTES UNIVERSITY HOSPITAL   (France)

^c Hopital Mere Enfant CHU de Nantes   (France)

^d UNIVERSITY HOSPITAL OF SAINT ETIENNE   (France)

Author keywords

Mononeuritis multiplex; Motor neuropathy; Neurotoxicity; Pediatric cancers; Toxic neuropathy; Vincristine

Indexed keywords

VINCRISTINE; ANTINEOPLASTIC AGENT;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ARTICLE; CHILD; CLINICAL ARTICLE; ELECTRODIAGNOSIS; ELECTROPHYSIOLOGY; FEMALE; HODGKIN DISEASE; HUMAN; LEG PAIN; LEUKEMIA; MALE; NEUROPATHY; PERIPHERAL NEUROPATHY; PRESCHOOL CHILD; PRIORITY JOURNAL; PSYCHOMOTOR DISORDER; SCHOOL CHILD; WALKING DIFFICULTY; ACTION POTENTIAL; CHEMICALLY INDUCED; ELECTROMYOGRAPHY; INFANT; NERVE CONDUCTION; PERIPHERAL NERVOUS SYSTEM DISEASES; PHYSIOLOGY; RETROSPECTIVE STUDY;

ACTION POTENTIALS; ADOLESCENT; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CHILD; CHILD, PRESCHOOL; ELECTROMYOGRAPHY; FEMALE; HUMANS; INFANT; MALE; NEURAL CONDUCTION; PERIPHERAL NERVOUS SYSTEM DISEASES; RETROSPECTIVE STUDIES; VINCRISTINE;

EID: 84955181843     PISSN: 0148639X     EISSN: 10974598     Source Type: Journal    
DOI: 10.1002/mus.24647     Document Type: Article

References (23)

1. Himes RH, Kersey RN, Heller-Bettinger I, Samson FE. Action of the vinca alkaloids vincristine, vinblastine, and desacetyl vinblastine amide on microtubules in vitro. Cancer Res 1976;36:3798-3802.
2. Guihéneuc P, Ginet J, Groleau JY, Rojouan J. Early phase of vincristine neuropathy in man. Electrophysiological evidence for a dying-back phenomenon, with transitory enhancement of spinal transmission of the monosynaptic reflex. J Neurol Sci 1980;45:355-366.
3. Bradley WG, Lassman LP, Pearce GW, Walton JN. The neuromyopathy of vincristine in man. Clinical, electrophysiological and pathological studies. J Neurol Sci 1970;10:107-131.
4. McLeod JG, Penny R. Vincristine neuropathy: an electrophysiological and histological study. J Neurol Neurosurg Psychiatry 1969;32:297-304.
5. Casey EB, Jellife AM, Le Quesne PM, Millett YL. Vincristine neuropathy. Clinical and electrophysiological observations. Brain 1973;96:69-86.
6. Sandler SG, Tobin W, Henderson ES. Vincristine-induced neuropathy. A clinical study of fifty leukemic patients. Neurology 1969;19:367-374.
7. Holland JF, Scharlau C, Gailani S, Krant M, Olson K, Horton J, et al. Vincristine treatment of advanced cancer: a cooperative study of 392 cases. Cancer Res 1973;33:1258-1264.
8. Yalin SF, Trabulus S, Yalin AS, Yalin GY, Ongoren S, Altiparmak MR. Vocal cord paralysis during the treatment of mantle cell lymphoma with vincristine. Int J Clin Pharm 2013;35:306-308.
9. Ryan SP, DelPrete SA, Weinstein PW, Erichson RB, Bar MH, Lo KM, et al. Low-dose vincristine-associated bilateral vocal cord paralysis. Conn Med 1999;63:583-584.
10. Dorchin M, Masoumi Dehshiri R, Soleiman S, Manashi M. Evaluation of neuropathy during intensive vincristine chemotherapy for non-Hodgkin's lymphoma and acute lymphoblastic leukemia. Iran J Ped Hematol Oncol 2013;3:138-142.
11. Péréon Y, Nguyen The Tich S, Fournier E, Genet R, Guihéneuc P. Electrophysiological recording of deep tendon reflexes: normative data in children and in adults. Neurophysiol Clin 2004;34:131-139.
12. Pal PK. Clinical and electrophysiological studies in vincristine induced neuropathy. Electromyogr Clin Neurophysiol 1999;39:323-330.
13. Gomber S, Dewan P, Chhonker D. Vincristine induced neurotoxicity in cancer patients. Indian J Pediatr 2010;77:97-100.
14. Jain P, Gulati S, Seth R, Bakhshi S, Toteja GS, Pandey RM. Vincristine-induced neuropathy in childhood ALL (acute lymphoblastic leukemia) survivors: prevalence and electrophysiological characteristics. J Child Neurol 2013;29:932-937.
15. Ramchandren S, Leonard M, Mody RJ, Donohue JE, Moyer J, Hutchinson R, et al. Peripheral neuropathy in survivors of childhood acute lymphoblastic leukemia. J Peripher Nerv Syst 2009;14:184-189.
16. Reinders-Messelink HA, van Weerden TW, Fock JM, Gidding CE, Vingerhoets HM, Schoemaker MM, et al. Mild axonal neuropathy of children during treatment for acute lymphoblastic leukaemia. Eur J Paediatr Neurol 2000;4:225-233.
17. Levitt LP, Prager D. Mononeuropathy due to vincristine toxicity. Neurology 1975;25:894-895.
18. Matsubara K, Nigami H, Harigaya H, Osaki M, Baba K. Peroneal mononeuropathy in pediatric Hodgkin's disease. Leuk Lymphoma 2000;40:205-207.
19. Latiff ZA, Kamal NA, Jahendran J, Alias H, Goh BS, Syed Zakaria SZ, et al. Vincristine-induced vocal cord palsy: case report and review of the literature. J Pediatr Hematol Oncol 2010;32:407-410.
20. Weimer LH, Podwall D. Medication-induced exacerbation of neuropathy in Charcot Marie Tooth disease. J Neurol Sci 2006;242:47-54.
21. Clavel J, Goubin A, Auclerc MF, Auvrignon A, Waterkeyn C, Patte C, et al. Incidence of childhood leukaemia and non-Hodgkin's lymphoma in France: National Registry of Childhood Leukaemia and Lymphoma, 1990-1999. Eur J Cancer Prev 2004;13:97-103.
22. Viala K. Neurological complications of lymphomas. Rev Neurol (Paris) 2006;162:1273-1278.
23. Beijers AJM, Jongen JLM, Vreugdenhil G. Chemotherapy-induced neurotoxicity: the value of neuroprotective strategies. Neth J Med 2012;70:18-25.